Takeda

Takeda is a global biopharmaceutical company that puts patients first and is driven by values and innovation in research and development. Takeda is committed to bringing groundbreaking scientific advancements to patients worldwide. Takeda focuses on drug development in four therapeutic areas: oncology, gastroenterology, neuroscience, and rare diseases, with dedicated investments in plasma-derived therapies and vaccines. We consistently concentrate on the development of highly innovative drugs, creating a robust and diversified pipeline through pioneering new treatment options and enhancing our collaborative R&D capabilities to improve people's lives. Our employees are located in approximately 80 countries and regions, working hand-in-hand with local healthcare partners to bring health benefits to patients globally. Takeda entered China in 1994, with its China headquarters in Shanghai. Its main business centers in China are located in Beijing, Shanghai, Tianjin, Guangzhou, and the Hong Kong Special Administrative Region, with offices set up in major cities across the country. Takeda currently has about 2,800 employees in China. With the continuous development of China’s economy and the growing demand for healthcare, China has become one of Takeda’s most important emerging markets globally.